MedPath
NMPA Approval

Recombinant Human Lutropin alfa for Injection

国药准字SJ20181005

October 10, 2022

S20181005

Drug Information

注射用重组人促黄体激素α

乐芮

注射剂

75IU

生物制品

October 10, 2022

October 9, 2027

Company Information

Applicant Company

Merck Europe BV

Gustav Mahlerplein 102,1082 MA Amsterdam,The Netherlands

Manufacturing Company

merck serono s.a., succursale d'aubonne

Zone Industrielle de l'Ouriettaz, 1170 Aubonne, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用重组人促黄体激素α - NMPA 批准文号 | MedPath